SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-18-000165
Filing Date
2018-11-07
Accepted
2018-11-07 08:33:53
Documents
3
Period of Report
2018-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2018q3earnings.htm 8-K 29478
2 EXHIBIT 99.1 a8-k2018q3earningsex991.htm EX-99.1 140676
3 blphlogoa43.jpg GRAPHIC 32979
  Complete submission text file 0001600132-18-000165.txt   216913
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 181164812
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1